Tip of the Iceberg: Assessing the Global Socioeconomic costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders

Manuscript Number: 

19-0426

Author(s): 
Alireza Atri, Clive G. Ballard, Ritesh P. Daya, Youssef H. El-Hayek, Alison R. Evans, Michael Karran, Charles P. Khoury, José-Luis Molinuevo, Matthew Norton, Ryan E. Wiley

Disclosures

Alireza Atri

  • Consulting Fees:
    In the past two years, I have served on medical/scientific advisory or independent data monitoring boards and received, or may receive, fees/honoraria for consulting from the following: AbbVie, Allergan, Axovant, Biogen, Eisai, Lundbeck, Grifols, Roche/Genentech, Suven, and Synexus.
    Patents/Royalties
    I receive book royalties from Oxford University Press as a co-author and co-editor of book on Dementia.
    Grants
    • Agency: 
      Grant support to my institution by Novartis for API (GENERATION Program) and iMAP (site PI) studies
      Dates: 
      2018-
    • Agency: 
      Grant support to my institution by The Global Alzheimer's Platform (GAP)
      Dates: 
      2019-2020

Clive G. Ballard

  • Consulting Fees:
    Consulting fees for Acadia, Lundbeck, E Lilly, Roche, Otusaka, Axion and Heptares pharmaceutical companies within the last 3 years
    Lecture Fees:
    Lecture fees from Acadia, Lundbeck, Axion and E Lilly pharmaceutical companies within the last 2 years.
    Grants
    • Agency: 
      Acadia pharmaceutical company
      Dates: 
      2013-2017

Ritesh P. Daya

  • Equity:
    My registered savings portfolio includes shares in a diverse range of companies across industry sectors; in no instance do my holdings constitute a significant equity stake in any of the organizations in which I have invested
    Sponsors:
    Employed under contract with Hoffman-La Roche Ltd. for the purposes of this work

Youssef H. El-Hayek

  • Sponsors:
    Employed under contract with Hoffman-La Roche Ltd. for the purposes of this work.

Alison R. Evans

  • Nothing to Disclose

Michael Karran

  • Nothing to Disclose

Charles P. Khoury

  • Equity:
    My registered retirement savings portfolio includes shares in a diverse range of companies across industry sectors; in no instance do my holdings constitute a significant equity stake in any of the organizations in which I have invested.
    Sponsors:
    Employed under contract with Hoffman-La Roche Ltd. for the purposes of this work.

José-Luis Molinuevo

  • Nothing to Disclose

Matthew Norton

  • Nothing to Disclose

Ryan E. Wiley

  • Equity:
    My registered retirement savings portfolio includes shares in a diverse range of companies across industry sectors; in no instance do my holdings constitute a significant equity stake in any of the organizations in which I have invested.
    Sponsors:
    Employed under contract with Hoffman-La Roche Ltd. for the purposes of this work.